Cargando…

Correlation of 3DCRT and Open Field Treatment Techniques in Advanced Head and Neck Cancer Patients Treated by Chemoradiation

BACKGROUND: Multimodality treatment is required for the management of head and neck cancer. Functional impairment and toxicities associated with surgery and radiation accentuate the need to develop innovative therapeutic strategies in the management of these patients to improve survival and reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sachan, Anjali, Gupta, Seema, Singh, Navin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819266/ https://www.ncbi.nlm.nih.gov/pubmed/35155296 http://dx.doi.org/10.31661/jbpe.v0i0.2007-1132

Ejemplares similares

A Comparison of the Toxicities in Patients With Locally Advanced Head and Neck Cancers Treated With Concomitant Boost Radiotherapy Versus Conventional Chemoradiation
por: Sharma, Ritu, et al.
Publicado: (2023)

Assessment of the Role of Gefitinib With Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
por: Prajapati, Raju, et al.
Publicado: (2022)

A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation
por: Baxi, Shrujal S., et al.
Publicado: (2016)

Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review
por: Jacobi, Irene, et al.
Publicado: (2010)

Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures
por: Sachan, Anjali, et al.
Publicado: (2021)

A Unique Complication Associated with Concurrent Chemoradiation for the Treatment of Locally Advanced Head and Neck Cancer
por: Cahlon, Oren, et al.
Publicado: (2008)

Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
por: Yu, Brian, et al.
Publicado: (2023)

Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation
por: Kaźmierska, Joanna, et al.
Publicado: (2023)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine
por: Pattanayak, Lucy, et al.
Publicado: (2016)

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy
por: Iovoli, Austin J., et al.
Publicado: (2020)

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer
por: Cmelak, Anthony, et al.
Publicado: (2020)

Dosimetric comparative study of 3DCRT, IMRT, VMAT, Ecomp, and Hybrid techniques for breast radiation therapy
por: Chen, Semaya Natalia, et al.
Publicado: (2020)

Comparison of whole breast dosimetry techniques – From 3DCRT to VMAT and the impact on heart and surrounding tissues
por: Lamprecht, Brock, et al.
Publicado: (2021)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
por: Judge, Lauren F., et al.
Publicado: (2021)

Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation
por: Rivers, Charlotte I., et al.
Publicado: (2021)

Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers
por: Sreenivas, Athulya, et al.
Publicado: (2021)

The Effect of Radiation and Chemoradiation Therapy on the Head and Neck Mucosal Microbiome: A Review
por: Zagury-Orly, Ivry, et al.
Publicado: (2021)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation
por: Wei, Yuchun, et al.
Publicado: (2022)

Dosimetric comparison of IMRT versus 3DCRT for post-mastectomy chest wall irradiation
por: Rastogi, Kartick, et al.
Publicado: (2018)

Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost
por: Zhao, Jun, et al.
Publicado: (2015)

Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma
por: Kang, Myoung Hee, et al.
Publicado: (2015)

Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation – a randomised trial
por: Patil, Vijay, et al.
Publicado: (2023)

Analysis of pharyngeal edema post‐chemoradiation for head and neck cancer: Impact on swallow function
por: Turcotte, Maria C., et al.
Publicado: (2018)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
por: van der Vorst, Maurice J. D. L., et al.
Publicado: (2019)

Valproic acid combined with cisplatin-based chemoradiation in locally advanced head and neck squamous cell carcinoma patients and associated biomarkers
por: Mak, Milena Perez, et al.
Publicado: (2020)

CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients
por: Verrelle, Pierre, et al.
Publicado: (2021)

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC
por: Colbert, Lauren E., et al.
Publicado: (2017)

Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis
por: Hu, Xingsheng, et al.
Publicado: (2016)

Dose measurements in a thorax phantom at 3DCRT breast radiation therapy
por: Pimenta, Elsa Bifano, et al.
Publicado: (2021)

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
por: Mallick, Supriya, et al.
Publicado: (2015)

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
por: Melotek, James M., et al.
Publicado: (2016)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2njq79slabhtrd3rjncbd6b1sr